Maike Wolff

Title: Maike Wolff: Innovator in Pharmaceutical Chemistry

Introduction

Maike Wolff is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on alkyl carbamate-substituted β-lactones. His research has implications for the development of new pharmaceutical compositions.

Latest Patents

Maike Wolff holds a patent for "Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them." This patent describes substituted β-lactones (oxetanones) that correspond to a specific formula, wherein R, R', and n have defined meanings as outlined in the specification. The pharmaceutical compositions derived from these compounds exhibit a pancreatic lipase-inhibiting action, which is crucial for certain therapeutic applications. The patent also details the process for preparing these compounds and their intermediate products.

Career Highlights

Wolff is currently associated with Solvay Pharmaceuticals GmbH, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new compounds that can potentially improve health outcomes.

Collaborations

Throughout his career, Maike has collaborated with esteemed colleagues, including Jochen Antel and Sabine Eyting. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Maike Wolff's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in therapeutic compositions.